organizations, could be a huge boon to possibilities in the treatment of epilepsy, and patients
withepilepsybyextension. Toaccommodateandfacilitatetheaforementionedsharingofdata
and experiences, however, a need for open and structured systems and forums exists. Here,
clinicians, researchers, developers, manufacturers, as well as patients could collaborate and
contribute to the advancement of the treatment of epilepsy with the use of wearable devices.
And although strict data protection rules like the EU GDPR may hinder collaboration, these
restrictions do not negate the major benefits of sharing pseudonymized or anonymized data